Contract 75A50118D00036
Genentech Inc · Department Of Health And Human Services · September 22, 2021
Genentech Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 22, 2021 for $57.55 million of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost sharing contract pricing. The most recent modification was on March 26, 2026. If all options are exercised, the contract could reach $628.60 million.
Contract details
- PIID
- 75A50118D00036
- Award type
- —
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 22, 2021
- Latest action
- March 26, 2026
Description
THE PURPOSE OF THIS NO COST MOD IS TO REVISE ARTICLE IV, TO UPDATE GENENTECH'S VOTER FOR ALTEPLASE AND TO MODIFY THE STATEMENT OF WORK TO UPDATE ELIMINATE SUBCLIN PERIOD OF PERFORMANCE DATES.
Modification timeline
-
March 26, 2026Mod P00025 · Supplemental Agreement For Work Within Scope$243.70M
-
October 1, 2025Mod P00024 · Other Administrative ActionTHE PURPOSE OF THIS NO COST MODIFICATION IS TO REVISE ARTICLE V, AGREEMENT ADMINISTRATION B, REPLACE THE GOVERNMENT POINTS OF CONTACT.$243.70M
-
September 26, 2024Mod P00018 · Exercise An OptionEXERCISE CLIN 0012 FOR TBI DIAGNOSTIC AND MONITORING AND EXTEND CLIN 0009 COVASTIL PERIOD OF PERFORMANCE.$243.70M
-
September 24, 2022Mod P00011 · Supplemental Agreement For Work Within ScopeGENENTECH UMBRELLA AGREEMENT$243.70M
-
September 22, 2021Mod P00009 · Supplemental Agreement For Work Within ScopeGENENTECH UMBRELLA AGREEMENT$243.70M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50118D00036?
Contract 75A50118D00036 is a federal contract awarded to Genentech Inc by Department Of Health And Human Services on September 22, 2021 for $57.55 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75A50118D00036?
Genentech Inc won contract 75A50118D00036 from Department Of Health And Human Services.
How much is contract 75A50118D00036 worth?
Contract 75A50118D00036 has obligated $57.55 million to date, with a total potential value of $628.60 million if all options are exercised.